Atlas Trials

Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia

Clinical trial NCT01772420 · COMPLETED

Trial details

NCT number
NCT01772420
Sponsor
Albert Einstein College of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Adult Myelodysplastic SyndromeAnemiaChronic Myelomonocytic Leukemia
Start date
2012-10-01
Primary completion
2020-07-09
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.